Z

Zeiss

Manufactures high-precision optical instruments and devices

Head of Business Development & Field Marketing - Semiconductor Mask Shop & Metrology

Full-TimeUpdated on 10/23/2026
$132k - $165k/yr+ Performance bonus + Sales commissions
Expert
Master's, MBA, PhD
Boise, ID, USA+1 moreMore locations: Dublin, CA, USA
HybridHybrid roles in Boise and Dublin, California; domestic and international travel required, up to 50%.
Growth & MarketingMarketing Generalist & Management
Company Does Not Provide H1B Sponsorship

About the job

Requirements
  • A master's degree in engineering, natural sciences, or a related STEM discipline, such as mechanical engineering, optics, physics, or materials science is required.
  • A PhD and/or business qualification, such as an MBA, is preferred.
  • At least 10 years of technical and commercial experience in the semiconductor industry, with strong relevance to Semiconductor Mask Solutions and the photomask ecosystem is required.
  • Experience in technical marketing, field marketing, market development, or go-to-market strategy in the semiconductor industry is required.
  • Experience translating complex technical products into customer value propositions and differentiated market positioning is required.
  • Experience identifying new market opportunities and developing strategies to increase customer adoption and business growth is required.
  • Experience measuring the effectiveness of market development and customer engagement initiatives is required.
  • Leadership experience building teams, functions, or cross-functional capabilities is required.
  • Domestic and international travel of up to 50% is required.
Responsibilities
  • Identify, qualify, and develop new business opportunities across the semiconductor photomask manufacturing, inspection, metrology, and repair ecosystem through strategic customer engagement, partnerships, joint development initiatives, and technology evaluations.
  • Develop regional market expansion initiatives to increase ZEISS SMS market penetration, expand customer relationships, and identify new applications and opportunities for portfolio growth.
  • Translate customer needs, market trends, and competitive intelligence into actionable business development priorities aligned with SMS strategy.
  • Contribute regional customer and competitive insights to product roadmaps, new product introductions, strategic partnerships, and commercial planning.
  • Align regional market development activities with SMS headquarters to support global business priorities and sustainable commercial growth.
  • Lead customer-facing technical marketing and market development activities that communicate the value, differentiation, and business benefits of ZEISS SMS products and solutions.
  • Develop customer-specific value propositions based on technical requirements, operational challenges, market trends, and competitive positioning.
  • Identify emerging customer needs, untapped market segments, and new application opportunities to expand awareness, interest, and adoption of the SMS portfolio.
  • Plan and coordinate customer technology exchanges, technical workshops, product demonstrations, and solution evaluations in partnership with Sales, Applications, and Service.
  • Develop targeted market development initiatives that strengthen ZEISS’s visibility, customer engagement, and competitive position within the semiconductor photomask ecosystem.
  • Partner with the Head of Sales and regional Sales teams to identify growth opportunities, prioritize target customers, and support the progression of qualified opportunities toward commercial outcomes.
  • Collaborate with the Head of Applications and Applications teams to align customer requirements with technical capabilities, support solution evaluations, and communicate product value.
  • Partner with the Head of Service and Service teams to identify service growth opportunities, strengthen customer relationships, and support customer retention and expanded portfolio adoption.
  • Coordinate cross-functional market development and new product introduction initiatives from opportunity identification through customer evaluation, qualification, adoption, and repeat business.
  • Establish clear collaboration practices and responsibilities across Business Development & Field Marketing, Sales, Applications, and Service to ensure coordinated customer engagement and execution without duplicating functional ownership.
  • Establish and develop the Business Development & Field Marketing function, defining its structure, responsibilities, operating processes, and collaboration model with Sales, Applications, and Service.
  • Provide functional leadership, coaching, and professional development to build the team's business development, technical marketing, and market development capabilities.
  • Define and monitor key performance indicators to assess market development effectiveness, customer engagement, qualified opportunity generation, product adoption, and contribution to business growth.
  • Use market insights and performance results to prioritize resources, refine field marketing initiatives, and continuously improve regional growth strategies.

About the company

ZEISS is a global leader in optics and optoelectronics, serving medical professionals, industrial manufacturers, consumers, and the semiconductor industry. It designs and sells high-precision optical instruments, medical devices, semiconductor manufacturing equipment, and vision care products such as corrective lenses and eye-health services. Its products rely on advanced optics and imaging technologies to deliver accurate inspection, diagnosis, and manufacturing outcomes across healthcare, industrial quality control, consumer optics, and chip fabrication. What sets ZEISS apart is its breadth and depth: a long-standing scale in multiple markets, integrated solutions across optics, imaging, metrology, and precision engineering, and a commitment to sustainability in electricity use and carbon emissions. The company’s goal is to advance optics and optoelectronics by providing reliable, high-quality tools and services worldwide while operating in a sustainable way.

Company Size

1,001-5,000

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$67.7M

Headquarters

Oberkochen, Germany

Founded

2001

Get referred to Zeiss

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • First-half 2025/26 revenue reached €5.841 billion, with EBIT rising to €955 million.
  • ZEISS CLINIC 360 won FDA 510(k) clearance on August 19, 2026.
  • EURETINA 2026 launches expanded retina imaging, cataract systems, and DORC brand integration.

What critics are saying

  • ZEISS Meditec plans up to 1,000 cuts by 2029, signaling margin pressure.
  • Göttingen workers entered mediation in February 2026 after Zeiss targeted roughly 140 jobs.
  • ASML scanner timing controls ZEISS SMT revenue; any slip delays optics demand immediately.

What makes Zeiss unique

  • ZEISS supplies ASML's exclusive EUV optics, anchoring High-NA lithography through 2030.
  • ZEISS Medical Technology bundles imaging, software, and surgery across one ophthalmic workflow stack.
  • ZEISS CLINIC 360 and Collaborative Care tie devices, cloud analytics, and referrals together.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • 401(k) Retirement Plan
  • Paid Vacation
  • Performance Bonus

Growth & Insights and Company News

6 month growth

5%

1 year growth

4%

2 year growth

4%
Yahoo Finance
Oct 26th, 2026
Bronwyn Brophy O'Connor to lead Carl Zeiss Meditec as CEO from December 1, 2026

Bronwyn Brophy O'Connor, currently chief executive officer of Sweden's Vitrolife Group, will become CEO of Carl Zeiss Meditec AG on December 1, 2026. She will also join the Executive Board of Carl Zeiss AG, where she will lead the Medical Technology segment. She succeeds Andreas Pecher, who has served as interim CEO since January 1, 2026, alongside his role as chief executive of the ZEISS Group. Her appointment was first announced in May 2026. Brophy O'Connor has led Vitrolife since 2023. Her earlier roles include posts at Johnson & Johnson, Medtronic, and Thermo Fisher Scientific. Justus Wehmer will serve as chief financial officer of Carl Zeiss Meditec. The company generated revenue of €2,228 million in fiscal year 2024/25.

PR Newswire
Oct 22nd, 2026
ZEISS launches CT LUCIA 621P monofocal lens in Japan, expanding its Cataract Workflow

ZEISS Medical Technology has launched its CT LUCIA 621P monofocal intraocular lens (IOL) in Japan, adding it to the ZEISS Cataract Workflow. The company announced the move on October 22, 2026. The lens uses a proprietary asphericity concept to account for the natural misalignment between the cornea centre and the eye's optical axis. ZEISS says this supports consistent visual outcomes across a wide range of patients. It also has a reinforced optic-haptic junction and step-vaulted C-loop haptics, designed to ease centring and help keep the lens stable in the bag. ZEISS will show the lens at the 80th Annual Congress of Japan Clinical Ophthalmology in Kyoto from October 29 to November 1, 2026.

Associated Press
Oct 12th, 2026
ZEISS launches NLX X-ray inspection and DUNE wafer warpage correction for advanced chip packaging

ZEISS Semiconductor Manufacturing Technology (SMT) has launched two systems for advanced chip packaging: ZEISS NLX and ZEISS DUNE. The company announced them in San Francisco on October 12, 2026, as chips grow more complex. ZEISS NLX inspects the inside of chip packages without damaging them. It helps manufacturers spot defects in connections between stacked dies early, and it handles 300-millimetre wafers in both process development and high-volume production. ZEISS DUNE measures the topography of a wafer and corrects wafer bow individually. This helps avoid yield losses in downstream processing and prepares bonding processes. ZEISS SMT is showing the systems at SEMICON West, alongside its photomask tools. The company is also marking 100 years of business in the US in 2026.

PR Newswire
Sep 24th, 2026
ZEISS unveils retinal imaging and surgical innovations at EURETINA 2026

ZEISS Medical Technology has announced expansions to its ZEISS Retina Workflow at the EURETINA 2026 congress in Vienna. The company introduced the ZEISS ALTA DUO 300, combining OCT and fundus imaging in a single device for streamlined retinal diagnostics. ZEISS also unveiled the HMDmd CR3, a head-mounted 3D display that connects with the ZEISS ARTEVO 850 surgical microscope. The company reported that its DORC ILM-BLUE and DORC MEMBRANEBLUE-DUAL vitreoretinal surgical dyes reached a 3 million milestone. Additionally, ZEISS announced that the DORC brand will be consolidated under the ZEISS brand name, unifying the company's ophthalmic offerings. The DORC TDC VELOCE cutter continues to show improvements in 27G vitrectomy procedures, with clinical data suggesting up to 41% shorter core vitrectomy times.

PR Newswire
Sep 17th, 2026
ZEISS expands retinal imaging portfolio with new ALTA DUO 300 multimodal OCT device

ZEISS Medical Technology has expanded its retinal imaging portfolio with the launch of ZEISS ALTA DUO 300, a fully automated, compact multimodal imaging solution. The device combines optical coherence tomography (OCT) and fundus photography in a single unit, designed to provide efficient retinal assessment for eye care practices. The ALTA DUO 300 features four key diagnostic technologies: automated structural OCT with reference database and reporting, true colour fundus camera, AI-enhanced OCT-Angiography, and full chamber depth anterior OCT scanning. The device aims to integrate retinal imaging into everyday patient care through simplified workflows. The product will be showcased at the European Society of Retina Specialists congress in Vienna from 1-4 October and will be available in select markets later in 2026.